PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsHistone-arginine methyltransferase carm1
Histone-arginine methyltransferase carm1
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
5849 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C801689233452316
Healthy volunteers/patients122105830169
Prostatic neoplasmsD011471C61367723143166
CarcinomaD002277C80.0327615413125
Diabetes mellitusD003920EFO_0000400E08-E131319211262122
Type 2 diabetes mellitusD003924EFO_0001360E111520241839115
Colorectal neoplasmsD015179354314127106
Hiv infectionsD015658EFO_0000764B20233812132299
LeukemiaD007938C954350112591
InfectionsD007239EFO_0000544162615122790
Show 390 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50611105455251
Non-small-cell lung carcinomaD00228966893811176
Lung neoplasmsD008175C34.9041562129129
LymphomaD008223C85.944399884
Multiple myelomaD009101C90.034288667
Squamous cell carcinoma of head and neckD00007719519398865
Myeloid leukemia acuteD015470C92.0273511564
Small cell lung carcinomaD055752242611352
Head and neck neoplasmsD006258192551152
Myelodysplastic syndromesD009190D4619279150
Show 386 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
UlcerD014456MPATH_579231015
Transitional cell carcinomaD00229579114
Neuroendocrine tumorsD018358EFO_1001901D3A.8511114
Biliary tract neoplasmsD001661C24.9210112
GliosarcomaD0183168710
ExerciseD015444EFO_00004831910
Ischemic strokeD00008324211810
Mantle-cell lymphomaD020522C83.1849
Precursor t-cell lymphoblastic leukemia-lymphomaD0542185519
Hearing lossD034381EFO_0004238H91.9279
Show 393 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD0105991010
Drug interactionsD004347718
Diagnostic imagingD00395288
Diabetic footD017719EFO_1001459167
Food diet and nutritionD000066888167
Cocaine-related disordersD019970F1466
Brain ischemiaD002545EFO_0003883I67.82156
Blood pressureD001794EFO_0004325156
Foot ulcerD016523145
HypoglycemiaD007003E16.2224
Show 99 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SleepD012890GO_003043199
Medication adherenceD055118EFO_000634488
Pediatric obesityD06376677
FrailtyD000073496R53.177
Healthy dietD00007200177
CommunicationD00314266
Child developmentD00265766
AdenomaD00023666
Weight gainD01543066
Surgical amputationD00067166
Show 609 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use